Marcus Bosenberg
Dermatopathology · Burlington, VTNPI 1679595094
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,966 of the $1,966 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, E.r. Squibb & Sons, L.L.C..
Across 1 payment — averaging $1966.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$2K
Across 4 payments — averaging $201,359 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$805K
What the payments were for
- Consulting fees$1,966100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 1 | $1,966 |
How this compares
Too few dermatopathology providers in Vermontto place this figure against a meaningful peer group, so we don't.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.